Lista de obras - Tai-Chung Tseng - Dominio Público Uruguay

Association of baseline viral factors with response to lamivudine therapy in chronic hepatitis B patients with high serum alanine aminotransferase levels.

artículo científico publicado en 2009

Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma

scientific article published on 25 January 2019

Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver Disease

artículo científico publicado en 2021

Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy

artículo científico publicado en 2013

Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: new trick of old dog ⬇️

artículo científico publicado el 24 de octubre de 2012

Consolidation therapy for HBeAg-positive Asian chronic hepatitis B patients receiving lamivudine treatment: a multicentre study

artículo científico publicado en 2013

Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load

artículo científico publicado en 2012

Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion.

artículo científico publicado en 2013

Distinct relapse rates and risk predictors after discontinuing tenofovir and entecavir therapy

artículo científico publicado en 2018

Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection

scientific article published on 27 December 2018

Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy

artículo científico publicado en 2011

Elimination of Hepatitis B: Is It a Mission Possible?

artículo científico publicado en 2017

Factors affecting the diagnostic accuracy of ultrasonography in assessing the severity of hepatic steatosis

scientific article published on 11 August 2012

Fibrosis-4 Index Helps Identify HBV Carriers With the Lowest Risk of Hepatocellular Carcinoma.

artículo científico publicado en 2017

Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infection.

artículo científico publicado en 2018

Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters

artículo científico publicado en 2014

Hepatitis B virus genotype B has an earlier emergence of lamivudine resistance than genotype C.

artículo científico publicado en 2009

Hepatitis B virus-specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation.

artículo científico publicado en 2018

Hepatitis C virus reinfection in people living with human immunodeficiency virus in Taiwan after achieving sustained virologic response with antiviral treatment: the RECUR study

artículo científico publicado en 2022

High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients With Low HBV Load ⬇️

artículo científico publicado el 11 de febrero de 2012

Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers.

artículo científico publicado en 2014

Host genetic factors affecting spontaneous HBsAg seroclearance in chronic hepatitis B patients

artículo científico publicado en 2013

Immunopathogenesis of Hepatitis B Virus.

artículo científico publicado en 2017

Impact of occult hepatitis B on the clinical outcomes of patients with chronic hepatitis C virus infection: A 10-year follow-up

artículo científico publicado en 2016

Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis.

artículo científico publicado en 2015

Longitudinal change of HBsAg in HBeAg-negative patients with genotype B or C infection

artículo científico publicado en 2013

More viral mutants, less HBsAg clearance? One size may not fit all.

artículo científico publicado en 2016

Perspectives on dual hepatitis B and C infection in Taiwan

artículo científico publicado en 2016

Predicting Hepatitis B Virus (HBV) Surface Antigen Seroclearance in HBV e Antigen-Negative Patients With Chronic Hepatitis B: External Validation of a Scoring System

artículo científico publicado en 2014

Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers.

artículo científico publicado en 2013

Sequential combination therapy for chronic hepatitis B: more challenges to be tackled

scientific article published on 01 July 2007

Serum Hepatitis B Surface Antigen Levels Help Predict Disease Progression in Patients With Low Hepatitis B Virus Loads ⬇️

artículo científico publicado el 6 de diciembre de 2012

Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters.

artículo científico publicado en 2011

Serum hepatitis B virus-DNA levels correlate with long-term adverse outcomes in spontaneous hepatitis B e antigen seroconverters.

artículo científico publicado en 2011

Severity of fatty liver on ultrasound correlates with metabolic and cardiovascular risk

artículo científico publicado en 2012

Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition

artículo científico publicado en 2015

Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in Taiwan.

artículo científico publicado en 2007

Young Chronic Hepatitis B Patients With Nucleos(t)ide Analogue-induced Hepatitis B e Antigen Seroconversion Have a Higher Risk of HBV Reactivation

artículo científico publicado en 2012

Lista de obras de Tai-Chung Tseng

Association of baseline viral factors with response to lamivudine therapy in chronic hepatitis B patients with high serum alanine aminotransferase levels.

Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma

Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver Disease

Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy

Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: new trick of old dog ⬇️

Consolidation therapy for HBeAg-positive Asian chronic hepatitis B patients receiving lamivudine treatment: a multicentre study

Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load

Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion.

Distinct relapse rates and risk predictors after discontinuing tenofovir and entecavir therapy

Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection

Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy

Elimination of Hepatitis B: Is It a Mission Possible?

Factors affecting the diagnostic accuracy of ultrasonography in assessing the severity of hepatic steatosis

Fibrosis-4 Index Helps Identify HBV Carriers With the Lowest Risk of Hepatocellular Carcinoma.

Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infection.

Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters

Hepatitis B virus genotype B has an earlier emergence of lamivudine resistance than genotype C.

Hepatitis B virus-specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation.

Hepatitis C virus reinfection in people living with human immunodeficiency virus in Taiwan after achieving sustained virologic response with antiviral treatment: the RECUR study

High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients With Low HBV Load ⬇️

Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers.

Host genetic factors affecting spontaneous HBsAg seroclearance in chronic hepatitis B patients

Immunopathogenesis of Hepatitis B Virus.

Impact of occult hepatitis B on the clinical outcomes of patients with chronic hepatitis C virus infection: A 10-year follow-up

Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis.

Longitudinal change of HBsAg in HBeAg-negative patients with genotype B or C infection

More viral mutants, less HBsAg clearance? One size may not fit all.

Perspectives on dual hepatitis B and C infection in Taiwan

Predicting Hepatitis B Virus (HBV) Surface Antigen Seroclearance in HBV e Antigen-Negative Patients With Chronic Hepatitis B: External Validation of a Scoring System

Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers.

Sequential combination therapy for chronic hepatitis B: more challenges to be tackled

Serum Hepatitis B Surface Antigen Levels Help Predict Disease Progression in Patients With Low Hepatitis B Virus Loads ⬇️

Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters.

Serum hepatitis B virus-DNA levels correlate with long-term adverse outcomes in spontaneous hepatitis B e antigen seroconverters.

Severity of fatty liver on ultrasound correlates with metabolic and cardiovascular risk

Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition

Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in Taiwan.

Young Chronic Hepatitis B Patients With Nucleos(t)ide Analogue-induced Hepatitis B e Antigen Seroconversion Have a Higher Risk of HBV Reactivation